title: Therapy-related myeloid neoplasms in epithelial ovarian cancer patients carrying BRCA1 mutation: report of two cases.
authors.forename: Bohuslav
authors.initials: B
authors.lastname: Melichar
authors.forename: Jan
authors.initials: J
authors.lastname: Laco
authors.forename: Petra
authors.initials: P
authors.lastname: Fridrichová
authors.forename: Martin
authors.initials: M
authors.lastname: Simkovič
authors.forename: Tomáš
authors.initials: T
authors.lastname: Papajík
authors.forename: Lenka
authors.initials: L
authors.lastname: Foretová
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000235:genetics / Q000628:therapy; D000077216:Carcinoma, Ovarian Epithelial; D018284:Cystadenocarcinoma, Serous / Q000235:genetics / Q000628:therapy; D017809:Fatal Outcome; D005260:Female; D019398:Genes, BRCA1; D006579:Heterozygote; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000139:chemically induced*; D008875:Middle Aged; D009154:Mutation; D009375:Neoplasms, Glandular and Epithelial / Q000188:drug therapy* / Q000235:genetics*; D016609:Neoplasms, Second Primary / Q000139:chemically induced*; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000235:genetics*; D017239:Paclitaxel / Q000008:administration & dosage / Q000009:adverse effects; D010984:Platinum / Q000008:administration & dosage / Q000009:adverse effects
chemical_list: D010984:Platinum; D017239:Paclitaxel